This proof-of-concept phase 1 trial shows that the size of circulating tumor cell clusters (which can promote metastatic spread) can be reduced by treatment with the Na+/K+ ATPase inhibitor digoxin in patients with metastatic breast cancer.
- Christian Kurzeder
- Bich Doan Nguyen-Sträuli
- Nicola Aceto